322 related articles for article (PubMed ID: 24619311)
1. The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease.
Hatton OL; Harris-Arnold A; Schaffert S; Krams SM; Martinez OM
Immunol Res; 2014 May; 58(2-3):268-76. PubMed ID: 24619311
[TBL] [Abstract][Full Text] [Related]
2. Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus.
Bouvet M; Voigt S; Tagawa T; Albanese M; Chen YA; Chen Y; Fachko DN; Pich D; Göbel C; Skalsky RL; Hammerschmidt W
mBio; 2021 Mar; 12(2):. PubMed ID: 33785626
[TBL] [Abstract][Full Text] [Related]
3. The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination.
Jochum S; Moosmann A; Lang S; Hammerschmidt W; Zeidler R
PLoS Pathog; 2012; 8(5):e1002704. PubMed ID: 22615564
[TBL] [Abstract][Full Text] [Related]
4. A Temporal Proteomic Map of Epstein-Barr Virus Lytic Replication in B Cells.
Ersing I; Nobre L; Wang LW; Soday L; Ma Y; Paulo JA; Narita Y; Ashbaugh CW; Jiang C; Grayson NE; Kieff E; Gygi SP; Weekes MP; Gewurz BE
Cell Rep; 2017 May; 19(7):1479-1493. PubMed ID: 28514666
[TBL] [Abstract][Full Text] [Related]
5. Deciphering the Role of Epstein-Barr Virus Latent Membrane Protein 1 in Immune Modulation: A Multifaced Signalling Perspective.
Šimičić P; Batović M; Stojanović Marković A; Židovec-Lepej S
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675906
[TBL] [Abstract][Full Text] [Related]
6. Tree Shrew Is a Suitable Animal Model for the Study of Epstein Barr Virus.
Xia W; Chen H; Feng Y; Shi N; Huang Z; Feng Q; Jiang X; He G; Xie M; Lai Y; Wang Z; Yi X; Tang A
Front Immunol; 2021; 12():789604. PubMed ID: 35111158
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome reprogramming of Epstein-Barr virus infected epithelial and B cells reveals distinct host-virus interaction profiles.
Ma N; Lu J; Pei Y; Robertson ES
Cell Death Dis; 2022 Oct; 13(10):894. PubMed ID: 36272970
[TBL] [Abstract][Full Text] [Related]
8. Immunity and Immune Evasion Mechanisms of Epstein-Barr Virus.
Yao Y; Kong W; Yang L; Ding Y; Cui H
Viral Immunol; 2023 Jun; 36(5):303-317. PubMed ID: 37285188
[TBL] [Abstract][Full Text] [Related]
9. The infectious kiss: newly infected B cells deliver Epstein-Barr virus to epithelial cells.
Bornkamm GW; Behrends U; Mautner J
Proc Natl Acad Sci U S A; 2006 May; 103(19):7201-2. PubMed ID: 16651525
[No Abstract] [Full Text] [Related]
10. Mechanisms of T cell evasion by Epstein-Barr virus and implications for tumor survival.
Sausen DG; Poirier MC; Spiers LM; Smith EN
Front Immunol; 2023; 14():1289313. PubMed ID: 38179040
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus: the mastermind of immune chaos.
Silva JM; Alves CEC; Pontes GS
Front Immunol; 2024; 15():1297994. PubMed ID: 38384471
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus regulates the life cycle and host cell biology by hijacking post-translational modification.
Zhang X; Zhang Y; Liu W; Luo B
Rev Med Virol; 2023 Jul; 33(4):e2447. PubMed ID: 37029718
[TBL] [Abstract][Full Text] [Related]
13. EBV Persistence--Introducing the Virus.
Thorley-Lawson DA
Curr Top Microbiol Immunol; 2015; 390(Pt 1):151-209. PubMed ID: 26424647
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus and host cell 3D genome organization.
Wang C; Zhao B
J Med Virol; 2023 Nov; 95(11):e29234. PubMed ID: 37988227
[TBL] [Abstract][Full Text] [Related]
15. An Epstein-Barr virus protein interaction map reveals NLRP3 inflammasome evasion via MAVS UFMylation.
Yiu SPT; Zerbe C; Vanderwall D; Huttlin EL; Weekes MP; Gewurz BE
Mol Cell; 2023 Jul; 83(13):2367-2386.e15. PubMed ID: 37311461
[TBL] [Abstract][Full Text] [Related]
16. Raman spectroscopy of lymphocytes from patients with the Epstein-Barr virus infection.
Pietruszewska M; Biesiada G; Czepiel J; Birczyńska-Zych M; Moskal P; Garlicki A; Wesełucha-Birczyńska A
Sci Rep; 2024 Mar; 14(1):6417. PubMed ID: 38494496
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of self-regulation of the epidemic process of infection caused by the Epstein-Barr virus (Herpesviridae:
Solomay TV; Semenenko TA; Akimkin VG
Vopr Virusol; 2023 Sep; 68(4):343-354. PubMed ID: 38156591
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus infectious particles initiate B cell transformation and modulate cytokine response.
Baccianti F; Masson C; Delecluse S; Li Z; Poirey R; Delecluse H-J
mBio; 2023 Oct; 14(5):e0178423. PubMed ID: 37830871
[TBL] [Abstract][Full Text] [Related]
19. Main Targets of Interest for the Development of a Prophylactic or Therapeutic Epstein-Barr Virus Vaccine.
Jean-Pierre V; Lupo J; Buisson M; Morand P; Germi R
Front Microbiol; 2021; 12():701611. PubMed ID: 34239514
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus infection: the micro and macro worlds.
Huang W; Bai L; Tang H
Virol J; 2023 Oct; 20(1):220. PubMed ID: 37784180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
